CoChat

Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009

Open access

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

AIMS/HYPOTHESIS: There is continuing debate about the net benefits of population screening for type 2 diabetes. We compared the risk of cardiovascular disease (CVD) and mortality among incident cases of type 2 diabetes in a screened group with those in an unscreened group. METHODS: In this register-based non-randomised controlled trial, eligible individuals were all men and women aged 40-69 years without known diabetes, registered with a general practice in Denmark (n = 1,912,392). Between 2001 and 2006, 153,107 individuals registered with 181 practices participating in the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION)-Denmark study were sent a diabetes-risk-score questionnaire. Individuals at moderate-to-high risk were invited to visit their family doctor for assessment of diabetes status and cardiovascular risk (screening group). The 1,759,285 individuals registered with all other practices in Denmark constituted the retrospectively constructed no-screening (control) group. In this post hoc analysis, we identified individuals from the screening and no-screening groups who were diagnosed with diabetes between 2001 and 2009 (n = 139,075), and compared risk of CVD and mortality in these groups between 2001 and 2012. RESULTS: In the screening group, 27,177/153,107 (18%) individuals attended for screening, of whom 1533 were diagnosed with diabetes. Between 2001 and 2009, 13,992 people were newly diagnosed with diabetes in the screening group (including those diagnosed by screening) and 125,083 in the no-screening group. Between 2001 and 2012, the risks of CVD and mortality were lower among individuals with diabetes in the screening group compared with individuals with diabetes in the no-screening (control) group (CVD HR 0.84, 95% CI 0.80, 0.89; mortality HR 0.79, 95% CI 0.74, 0.84). CONCLUSIONS/INTERPRETATION: A single round of diabetes screening and cardiovascular risk assessment in middle-aged Danish adults in general practice was associated with a significant reduction in risk of all-cause mortality and CVD events in those diagnosed with diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-017-4299-y

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Visual representation of sampling frame. The ‘S’ in a blue circle denotes individuals detected by the ADDITION stepwise screening programme. The ‘C’ in a red circle denotes individuals with clinically diagnosed diabetes
Fig. 1 Visual representation of sampling frame. The ‘S’ in a blue circle denotes individuals detected by the ADDITION stepwise screening programme. The ‘C’ in a red circle denotes individuals with clinically diagnosed diabetesCC BY · PubMed Central
Fig. 2 Cumulative incidence of all-cause mortality in individuals with diabetes in the screening and no-screening groups (2001 to 2012). The model is unadjusted. Solid line, no-screening (control) group; dashed line, screening group
Fig. 2 Cumulative incidence of all-cause mortality in individuals with diabetes in the screening and no-screening groups (2001 to 2012). The model is unadjusted. Solid line, no-screening (control) group; dashed line, screening groupCC BY · PubMed Central
Fig. 3 Cumulative incidence of a composite CVD event among individuals with diabetes in the screening and no-screening groups (2001 to 2012). The model is unadjusted. Solid line, no-screening (control) group; dashed line, screening group
Fig. 3 Cumulative incidence of a composite CVD event among individuals with diabetes in the screening and no-screening groups (2001 to 2012). The model is unadjusted. Solid line, no-screening (control) group; dashed line, screening groupCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 73

Metadata

Authors
Simmons, R. K., Griffin, S. J., Lauritzen, T., & Sandbæk, A.
Affiliations
Aarhus University (DK)
Corresponding author
Simmons, Rebecca K.
Venue
Diabetologia
Published
2017-08-23
Volume
60
Issue
11
Pages
2192-2199
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2749360885
Cited by
69
References
27
Citations by year
2026: 3 · 2025: 6 · 2024: 8 · 2023: 9 · 2022: 3 · 2021: 7 · 2020: 12 · 2019: 8 · 2018: 9 · 2017: 4
FWCI
8.47
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • Apollo (cc-by)
Funders
  • Pfizer
  • GlaxoSmithKline
  • Strategiske Forskningsråd
  • Aarhus Universitet
  • Sundhed og Sygdom, Det Frie Forskningsråd
  • National Institute for Health and Care Research (NF-SI-0515-10119)
  • Aarhus Universitets Forskningsfond
  • Novo Nordisk
  • Servier
  • Medical Research Council (MC_UU_12015/4)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 2 diabetes screening, cardiovascular disease, mortality, newly diagnosed diabetes, primary care screening, screening uptake, cardiovascular risk assessment
MeSH terms
Adult, Aged, Blood Glucose, Cardiovascular Diseases, Denmark, Diabetes Mellitus, Type 2, Female, Humans, Male, Mass Screening, Middle Aged, Primary Health Care, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009. https://app.cochat.ai/papers/10.1007/s00125-017-4299-y
The paper
Simmons, R. K., Griffin, S. J., Lauritzen, T., & Sandbæk, A. (2017). Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009. Diabetologia. https://doi.org/10.1007/s00125-017-4299-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.